|
1
|
Betarbet R, Sherer TB, MacKenzie G,
Garcia-Osuna M, Panov AV and Greenamyre JT: Chronic systemic
pesticide exposure reproduces features of Parkinson’s disease. Nat
Neurosci. 3:1301–1306. 2000.
|
|
2
|
Dawson TM and Dawson VL: Molecular
pathways of neurodegeneration in Parkinson’s disease. Science.
302:819–822. 2003.
|
|
3
|
Di Monte DA: The environment and
Parkinson’s disease: is the nigrostriatal system preferentially
targeted by neurotoxins? Lancet Neurol. 2:531–538. 2003.
|
|
4
|
Hartley A, Stone JM, Heron C, Cooper JM
and Schapira AH: Complex I inhibitors induce dose-dependent
apoptosis in PC12 cells: relevance to Parkinson’s disease. J
Neurochem. 63:1987–1990. 1994.PubMed/NCBI
|
|
5
|
Pitkanen S and Robinson BH: Mitochondrial
complex I deficiency leads to increased production of superoxide
radicals and induction of superoxide dismutase. J Clin Invest.
98:345–351. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Votyakova TV and Reynolds IJ:
ΔΨm-dependent and -independent production of reactive oxygen
species by rat brain mitochondria. J Neurochem. 79:266–277.
2001.
|
|
7
|
Liss B, Haeckel O, Wildmann J, Miki T,
Seino S and Roeper J: K-ATP channels promote the differential
degeneration of dopaminergic midbrain neurons. Nat Neurosci.
8:1742–1751. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Javoy-Agid F, Hirsch EC, Dumas S,
Duyckaerts C, Mallet J and Agid Y: Decreased tyrosine hydroxylase
messenger RNA in the surviving dopamine neurons of the substantia
nigra in parkinson’s disease: an in situ hybridization study.
Neuroscience. 38:245–253. 1990.
|
|
9
|
Mosmann T: Rapid colorimetric assay for
cellular growth and survival: application to proliferation and
cytotoxicity assays. J Immunol Methods. 65:55–63. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu C, Yang K, Liu Q, Wakui M, Jin GZ, Zhen
XC and Wu J: Tetrahydroberberine blocks ATP-sensitive potassium
channels in dopamine neurons acutely-dissociated from rat
substantia nigra pars compacta. Neuropharmacology. 59:567–572.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Koshimura K, Tanaka J, Murakami Y and Kato
Y: Effect of high concentration of glucose on dopamine release from
pheochromocytoma-12 cells. Metabolism. 52:922–926. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tai KK, McCrossan ZA and Abbott GW:
Activation of mitochondrial ATP-sensitive potassium channels
increases cell viability against rotenone-induced cell death. J
Neurochem. 84:1193–1200. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lamensdorf I, He LP, Nechushtan A,
Harvey-White J, Eisenhofer G, Milan R, Rojas E and Kopin IJ: Effect
of glipizide on dopamine synthesis, release and metabolism in PC12
cells. Eur J Pharmacol. 388:147–154. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liss B and Roeper J: ATP-sensitive
potassium channels in dopaminergic neurons: transducers of
mitochondrial dysfunction. News Physiol Sci. 16:214–217.
2001.PubMed/NCBI
|
|
15
|
Zingman LV, Hodgson DM, Bast PH, Kane GC,
Perez-Terzic C, Gumina RJ, Pucar D, Bienengraeber M, Dzeja PP, Miki
T, et al: Kir6.2 is required for adaptation to stress. Proc Natl
Acad Sci USA. 99:13278–13283. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Olson TM and Terzic A: Human
KATP channelopathies: diseases of metabolic homeostasis.
Pflugers Arch. 460:295–306. 2010.PubMed/NCBI
|
|
17
|
Van den Top M, Lyons DJ, Lee K, Coderre E,
Renaud LP and Spanswick D: Pharmacological and molecular
characterization of ATP-sensitive K+ conductances in
CART and NPY/AgRP expressing neurons of the hypothalamic arcuate
nucleus. Neuroscience. 144:815–824. 2007.PubMed/NCBI
|
|
18
|
Sherer TB, Betarbet R, Testa CM, Seo BB,
Richardson JR, Kim JH, Miller GW, Yagi T, Matsuno-Yagi A and
Greenamyre JT: Mechanism of toxicity in rotenone models of
Parkinson’s disease. J Neurosci. 23:10756–10764. 2003.
|
|
19
|
Tai KK and Truong DD: Activation of
ATP-sensitive potassium channel confers protection against
rotenone-induced cell death: therapeutic implications for
Parkinson’s disease. J Neurosci Res. 69:559–566. 2002.PubMed/NCBI
|
|
20
|
Saravanan KS, Sindhu KM and Mohanakumar
KP: Acute intranigral infusion of rotenone in rats causes
progressive biochemical lesions in the striatum similar to
Parkinson’s disease. Brain Res. 1049:147–155. 2005.PubMed/NCBI
|
|
21
|
Liu YM, Jiang B, Bao YM and An LJ:
Protocatechuic acid inhibits apoptosis by mitochondrial dysfunction
in rotenone-induced PC12 cells. Toxicol In Vitro. 22:430–437. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Islam MS, Berggren PO and Larsson O:
Sulfhydryl oxidation induces rapid and reversible closure of the
ATP-regulated K+ channel in the pancreatic β-cell. FEBS
Lett. 319:128–132. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Alekseev AE, Hodgson DM, Karger AB, Park
S, Zingman LV and Terzic A: ATP-sensitive K+ channel
channel/enzyme multimer: metabolic gating in the heart. J Mol Cell
Cardiol. 38:895–905. 2005.
|
|
24
|
Kastner A, Hirsch E, Agid Y and Javoy-Agid
F: Tyrosine hydroxylase protein and messenger RNA in the
dopaminergic nigral neurons of patients with Parkinson’s disease.
Brain Res. 606:341–345. 1993.PubMed/NCBI
|
|
25
|
Lee TM, Lin MS and Chang NC: Effect of
pravastatin on sympathetic reinnervation in postinfarcted rats. Am
J Physiol Heart Circ Physiol. 293:H3617–H3626. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
He XB, Yi SH, Rhee YH, Kim H, Han YM, Lee
SH, Lee H, Park CH, Lee YS, Richardson E, et al: Prolonged membrane
depolarization enhances midbrain dopamine neuron differentiation
via epigenetic histone modifications. Stem Cells. 29:1861–1873.
2011. View Article : Google Scholar
|
|
27
|
Kilbourne EJ, McMahon A and Sabban EL:
Membrane depolarization by isotonic or hypertonic KCl: differential
effects on mRNA levels of tyrosine hydroxylase and dopamine
β-hydroxylase mRNA in PC12 cells. J Neurosci Methods. 40:193–202.
1991.
|
